Thomas Okarma - Net Worth and Insider Trading
Thomas Okarma Net Worth
The estimated net worth of Thomas Okarma is at least $2 Million dollars as of 2024-11-13. Thomas Okarma is the President and CEO of Geron Corp and owns about 437,060 shares of Geron Corp (GERN) stock worth over $2 Million. Details can be seen in Thomas Okarma's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Okarma has not made any transactions after 2010-06-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Okarma
Thomas Okarma Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Okarma owns 2 companies in total, including Asterias Biotherapeutics Inc (AST) , and Geron Corp (GERN) .
Click here to see the complete history of Thomas Okarma’s form 4 insider trades.
Insider Ownership Summary of Thomas Okarma
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AST | Asterias Biotherapeutics Inc | 2013-09-27 | director & President and CEO |
| GERN | Geron Corp | 2010-06-02 | director & President and CEO |
Thomas Okarma Latest Holdings Summary
Thomas Okarma currently owns a total of 1 stock. Thomas Okarma owns 437,060 shares of Geron Corp (GERN) as of June 2, 2010, with a value of $2 Million.
Latest Holdings of Thomas Okarma
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GERN | Geron Corp | 2010-06-02 | 437,060 | 3.91 | 1,708,905 |
Holding Weightings of Thomas Okarma
Thomas Okarma Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Okarma has made a total of 0 transactions in Geron Corp (GERN) over the past 5 years. The most-recent trade in Geron Corp is the sale of 18,874 shares on June 2, 2010, which brought Thomas Okarma around $102,486.
Insider Trading History of Thomas Okarma
- 1
Thomas Okarma Trading Performance
Thomas Okarma Ownership Network
Ownership Network List of Thomas Okarma
Ownership Network Relation of Thomas Okarma
Thomas Okarma Owned Company Details
What does Asterias Biotherapeutics Inc do?
Who are the key executives at Asterias Biotherapeutics Inc?
Thomas Okarma is the director & President and CEO of Asterias Biotherapeutics Inc. Other key executives at Asterias Biotherapeutics Inc include other: See Remarks Below Neal C Bradsher , other: See Remarks Below Broadwood Partners Lp , and other: See Remarks Below Broadwood Capital Inc .
Asterias Biotherapeutics Inc (AST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Asterias Biotherapeutics Inc (AST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Asterias Biotherapeutics Inc (AST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Asterias Biotherapeutics Inc (AST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Asterias Biotherapeutics Inc Insider Transactions
Thomas Okarma Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Okarma. You might contact Thomas Okarma via mailing address: 230 Constitution Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
